Corona Announces TSX Approval of Normal Course Issuer Bid
Pursuant to the issuer bid, Corona may purchase for cancellation up to 1,180,778 of its outstanding common shares during the 12-month period commencing July 16, 2013 and ending July 15, 2014. The total aggregate number of common shares which Corona may purchase pursuant to the issuer bid represents approximately 5.5% (or 10% of the "public float" as such term is defined in TSX policies) of the 21,411,901 issued and outstanding common shares of Corona as at July 9, 2013.
The price which Corona will pay for any common shares purchased under the normal course issuer bid will be the market price at the time of such purchase. All purchases of common shares by Corona will be made through the facilities of TSX or other eligible designated exchanges and alternative trading platforms.
Other than as otherwise permitted pursuant to once-a-week block purchases in accordance with TSX rules, Corona may purchase up to 2,116 common shares per day, which represents approximately 25% of the Corona's average daily trading volume for the six calendar months prior to July 2013 (being 8,465 common shares). Over the past 12-months, Corona has repurchased 39,800 common shares at an average weighted price of $0.55 per share under the normal course issuer bid procedures of the TSX.
Corona believes that its common shares currently trade in a price range that does not adequately reflect their underlying value based on Corona's business and strong financial position. As a result, depending upon future price movements and other factors, Corona believes that its outstanding common shares represent an attractive investment and a desirable use of a portion of its corporate funds.
From time to time, when Corona does not possess material non-public information about itself or its securities, it may enter into a pre-defined automatic purchase plan with its broker to allow for the repurchase of shares at times when Corona ordinarily would not be active in the market due to its own internal trading blackout periods, insider trading rules or otherwise, as applicable. Any such plans entered into with Corona's broker will be adopted in accordance with applicable Canadian securities laws.
Forward-Looking Information:
This press release contains certain "forward-looking information". All statements, other than statements of historical fact, that address activities, events or developments that Corona believes, expects or anticipates will or may occur in the future (including, without limitation, statements relating to Corona purchasing its common shares under the normal course issuer bid or entering into a pre-defined automatic purchase plan) constitute forward-looking information. This forward-looking information reflects the current expectations or beliefs of Corona based on information currently available to Corona as well as certain assumptions including, without limitation, assumptions as to the price of Corona's common shares. Forward-looking information is subject to a number of significant risks and uncertainties and other factors that may cause the actual results of Corona to differ materially from those discussed in the forward- looking information, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on Corona. Factors that could cause actual results or events to differ materially from current expectations include, but are not limited to, a significant appreciation or decline in the price of Corona's common shares.
Any forward-looking information speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Corona disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise. Although Corona believes that the assumptions inherent in the forward- looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.
Contact
Corona Gold Corp.
Murray John
(416) 482-8606